Existing PGx results / GeneSight
Enter the genotypes from your GeneSight report and get a Gene2Rx Panel Report: every covered medication interpreted against current CPIC, FDA, and DPWG guidance, not just the ones on your original report.
Pick the two star alleles for each gene on your report, such as CYP2D6 *1/*4.
See which medications your results cover before you pay.
Your Panel Report is ready in your account within minutes, as a web page and a PDF.
Look for the section titled Patient Genotypes and Phenotypes. Each gene is listed with its genotype, such as CYP2C19 *1/*2, next to a metabolizer label. The genotype is what you enter. Layouts change between report versions, so go by the section title rather than a page number.
GeneSight's medication groups combine several genes using its own method. Gene2Rx interprets each gene with published CPIC, FDA, and DPWG guidance, so some medications may be grouped differently. How to read a GeneSight report.
GeneSight's sample report shows where this section is.
These cover most of the drug-metabolism genes on GeneSight, Genomind, and clinical PGx panel reports. CYP2D6 duplications (such as *2xN) and tandems (such as *36+*10) are supported.
You can also enter ABCG2, ADH1B, AKT1, ALDH2, BCHE, CACNA1S, CHRNA5, CYP2A6, FAAH, GIPR, GLP1R, IFNL3, NAT2, RYR1, SULT1A1, including single-variant results such as rs4680 G/A. Results reported only as a phenotype or a color category can't be entered, and genes such as HLA, MTHFR, SLC6A4, and HTR2A aren't supported. Medications that depend only on genes you don't enter won't be in your report.
$19 one time
Yes. Copy the genotype for each gene from the Patient Genotypes and Phenotypes section, such as CYP2C19 *1/*2, and Gene2Rx interprets it for every medication in its guideline set, not just the psychiatric medications GeneSight covers. The report costs $19 and no new sample is needed.
xN means the lab found extra copies of that allele without reporting how many. Choose the allele and "×N (not listed)". Gene2Rx assumes two copies, the most common count, and if a third copy would change your metabolizer status, your report says so and shows the result for both counts.
No. GeneSight's groups combine several genes using its own method. Gene2Rx interprets each gene with published CPIC, FDA, and DPWG guidance, so some medications may be grouped differently. A difference doesn't mean either report is wrong; discuss it with your clinician. How to read a GeneSight report.
No. We check that each genotype is one we can interpret, but we never see your laboratory report, so copy your results carefully. If you mistype a genotype, you can correct it later at no charge.
Raw data files cover more genes, so a report from your file is usually more complete. See our raw-data reports.
GeneSight is a trademark of its owner. Gene2Rx is independent and is not affiliated with or endorsed by GeneSight.